# Current hematologic malignancy reports

Source: https://onco.cc/journals/current-hematologic-malignancy-reports/  
OnCo record `current-hematologic-malignancy-reports` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Current Hematologic Malignancy Reports is a Springer review journal in which invited experts summarise recent papers on leukaemias, lymphomas, myeloma and related blood cancers, with annotated reference lists. Haematologist-oncologists and trainees use it to keep up; it is online only with hybrid access.

## Summary

Current Hematologic Malignancy Reports provides in-depth review articles contributed by international experts on recent developments in the field, presenting clear, balanced reviews that emphasise recently published papers that change practice or understanding, to elucidate current and emerging approaches to the diagnosis, treatment, management and prevention of conditions associated with haematological malignancy. The homepage lists a hybrid publishing model, and recent content includes reviews on acute lymphoblastic leukaemia immunotherapies, acute myeloid leukaemia variants, allogeneic transplantation and myelodysplastic syndromes, with topical collections on molecular testing and on chronic myelomonocytic leukaemia. The journal is online only and its print ISSN has ceased. NLM records the title from 2006, published quarterly in Philadelphia by Current Science, with print issues ceasing in October 2008, and indexed in MEDLINE and PubMed. Not listed in DOAJ.

## Fields

- Kind: Journal
- Last checked: 2026-09-10
- Also known as: Curr Hematol Malig Rep; Current Hematologic Malignancy Reports
- Publisher: Springer
- Scope: haematological oncology
- Access: hybrid

## Sources

- Homepage: https://link.springer.com/journal/11899
- NLM Catalog: https://www.ncbi.nlm.nih.gov/nlmcatalog/101262565

## Connected records

- collections: [PubMed & Europe PMC](https://onco.cc/collections/pubmed-europepmc/)
- cancers: [Acute lymphoblastic leukaemia](https://onco.cc/cancers/all-leukemia/), [Acute myeloid leukaemia](https://onco.cc/cancers/aml/), [Chronic lymphocytic leukaemia](https://onco.cc/cancers/cll/), [Chronic myeloid leukaemia (CML)](https://onco.cc/cancers/cml/), [Chronic myelomonocytic leukaemia and MDS/MPN overlap neoplasms](https://onco.cc/cancers/cmml/), [Diffuse large B-cell lymphoma](https://onco.cc/cancers/dlbcl/), [Follicular lymphoma](https://onco.cc/cancers/follicular-lymphoma/), [Hodgkin lymphoma](https://onco.cc/cancers/hodgkin-lymphoma/), [Mantle cell lymphoma](https://onco.cc/cancers/mantle-cell-lymphoma/), [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/), [Myelodysplastic syndromes / neoplasms (MDS)](https://onco.cc/cancers/mds/), [Myeloproliferative neoplasms (PV, ET, myelofibrosis)](https://onco.cc/cancers/myeloproliferative-neoplasms/)

---
JSON: https://onco.cc/api/v1/entities/current-hematologic-malignancy-reports.json